GALNT18
Polypeptide N-acetylgalactosaminyltransferase 18
Also known as: GalNAc-T18, GALNT15, GALNTL4, GLT18_HUMAN, MGC71806
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6P9A2
- Gene
- GALNT18
- Ensembl
- ENSG00000110328
- Chromosome
- 11
- Canonical length
- 607 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Vesicles,Cytosol
OverviewNCBI Gene
Enables polypeptide N-acetylgalactosaminyltransferase activity. Involved in protein O-linked glycosylation. Predicted to be located in Golgi membrane. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
607 residues, UniProt reviewed canonical sequence.
>Q6P9A2|GALNT18
1 MVCTRKTKTL VSTCVILSGM TNIICLLYVG WVTNYIASVY VRGQEPAPDK KLEEDKGDTL
61 KIIERLDHLE NVIKQHIQEA PAKPEEAEAE PFTDSSLFAH WGQELSPEGR RVALKQFQYY
121 GYNAYLSDRL PLDRPLPDLR PSGCRNLSFP DSLPEVSIVF IFVNEALSVL LRSIHSAMER
181 TPPHLLKEII LVDDNSSNEE LKEKLTEYVD KVNSQKPGFI KVVRHSKQEG LIRSRVSGWR
241 AATAPVVALF DAHVEFNVGW AEPVLTRIKE NRKRIISPSF DNIKYDNFEI EEYPLAAQGF
301 DWELWCRYLN PPKAWWKLEN STAPIRSPAL IGCFIVDRQY FQEIGLLDEG MEVYGGENVE
361 LGIRVWQCGG SVEVLPCSRI AHIERAHKPY TEDLTAHVRR NALRVAEVWM DEFKSHVYMA
421 WNIPQEDSGI DIGDITARKA LRKQLQCKTF RWYLVSVYPE MRMYSDIIAY GVLQNSLKTD
481 LCLDQGPDTE NVPIMYICHG MTPQNVYYTS SQQIHVGILS PTVDDDDNRC LVDVNSRPRL
541 IECSYAKAKR MKLHWQFSQG GPIQNRKSKR CLELQENSDL EFGFQLVLQK CSGQHWSITN
601 VLRSLASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GALNT18 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- lung: 49 nTPM
- thyroid gland: 41 nTPM
- kidney: 30 nTPM
- heart muscle: 26 nTPM
- blood vessel: 26 nTPM
- colon: 24 nTPM
Single-cell type
- vascular endothelial cells: 466 nCPM
- proximal tubule cells: 444 nCPM
- lymphatic endothelial cells: 426 nCPM
- sertoli cells: 408 nCPM
- loop of henle epithelial cells: 369 nCPM
- alveolar cells type 1: 360 nCPM
Immune cell
- gdT-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 56 nTPM
- cerebral cortex: 37 nTPM
- thalamus: 36 nTPM
- amygdala: 34 nTPM
- basal ganglia: 30 nTPM
- midbrain: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GALNT18 as an antibody target. Whether an autoantibody or antibody against GALNT18 could matter depends on whether native GALNT18 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GALNT18 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GALNT18 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...